Suitable for diazepam, midazolam, glucagon, and naloxone

The Single-Dose / Bi-Dose Nasal Delivery Platform (UDS/BDS) is designed for emergency treatment and pediatric applications, enabling the intranasal delivery of one or two predetermined doses of a liquid formulation. Its ready-to-use design requires no priming or complex preparation, and a single actuation delivers one complete dose, allowing rapid administration by patients, family members, or caregivers. The platform is suitable for drugs such as diazepam, midazolam, glucagon, and naloxone, supporting the development of emergency treatments for seizures, severe hypoglycemia, migraine, and opioid overdose. It provides a portable, non-invasive intranasal drug delivery solution.